Forte Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Forte Biosciences
FBRX Stock  USD 31.85  0.26  0.81%   
Forte Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Forte Biosciences' valuation are provided below:
Market Capitalization
172.1 M
Earnings Share
(3.68)
We have found one hundred twenty available fundamental signals for Forte Biosciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Forte Biosciences prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 72.3 M in 2026. Enterprise Value is likely to drop to about 48 M in 2026

Forte Biosciences Total Revenue

0.0

Check Forte Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Forte Biosciences' main balance sheet or income statement drivers, such as Interest Income of 1.3 M, Depreciation And Amortization of 33.3 K or Interest Expense of 14.5 K, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 1.38. Forte financial statements analysis is a perfect complement when working with Forte Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Forte Stock
Check out the analysis of Forte Biosciences Correlation against competitors.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Forte Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets43.8 M55.4 M56.3 M
Slightly volatile
Short and Long Term Debt Total13.5 M7.9 M13.9 M
Slightly volatile
Other Current Liabilities3.5 M3.8 M4.1 M
Pretty Stable
Total Current Liabilities6.1 M8.2 M7.1 M
Very volatile
Total Stockholder Equity44.9 M60.4 M41.7 M
Pretty Stable
Accounts Payable5.9 M5.6 M2.2 M
Slightly volatile
Cash30.1 M25.6 M21.8 M
Slightly volatile
Non Current Assets Total183.8 K193.5 K1.5 M
Slightly volatile
Non Currrent Assets Other118 K124.2 K1 M
Slightly volatile
Long Term Debt16.7 M30.1 M20.6 M
Slightly volatile
Cash And Short Term Investments41.5 M52.5 M53.4 M
Slightly volatile
Common Stock Total Equity9.9 K11.7 K13.1 K
Pretty Stable
Common Stock Shares Outstanding3.5 M3.4 M847.4 K
Slightly volatile
Short Term Investments29.6 M32.5 M38.2 M
Slightly volatile
Long Term Debt Total16.7 M30.1 M20.6 M
Slightly volatile
Liabilities And Stockholders Equity43.8 M55.4 M56.3 M
Slightly volatile
Capital Surpluse177.8 M333.7 M163.6 M
Slightly volatile
Other Current Assets3.6 M3.4 M1.5 M
Slightly volatile
Other Stockholder Equity125.4 M237.4 M89 M
Slightly volatile
Total Liabilities11.1 M8.2 M16.1 M
Slightly volatile
Total Current Assets42.6 M55.2 M54.8 M
Pretty Stable
Short Term Debt3.8 M5.5 M3.1 M
Slightly volatile
Common Stock6.6 K6.9 K9.6 K
Slightly volatile
Property Plant Equipment82.9 K87.3 K553.5 K
Pretty Stable
Capital Stock6.6 K6.9 K6.7 K
Slightly volatile
Net Working Capital42 M60.1 M22.5 M
Slightly volatile
Deferred Long Term Liabilities158 K95.4 K226.8 K
Slightly volatile

Forte Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income1.3 M1.5 M773 K
Slightly volatile
Depreciation And Amortization33.3 K35.1 K163.6 K
Slightly volatile
Selling General Administrative18.6 M17.7 M7.1 M
Slightly volatile
Selling And Marketing Expenses9.8 K10.3 K856.3 K
Very volatile
Other Operating Expenses22.3 M32.9 M26.4 M
Very volatile
Research Development16.1 M19.1 M19.5 M
Pretty Stable
Total Operating Expenses22.2 M32.9 M26.3 M
Very volatile
Tax Provision855900899.9 K
Slightly volatile
Net Interest Income1.6 M1.5 M355.7 K
Slightly volatile
Cost Of Revenue32.8 K44.9 K19.7 K
Slightly volatile

Forte Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow30.9 M42.7 M22.1 M
Slightly volatile
End Period Cash Flow32.8 M25.6 M23.4 M
Slightly volatile
Stock Based Compensation2.7 M2.8 M3.7 M
Slightly volatile
Net Borrowings504.1 K567.1 K619 K
Slightly volatile
Change To Netincome4.7 M4.9 M3.5 M
Slightly volatile
Issuance Of Capital Stock36.5 M61 M20 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.9810.52.1 K
Slightly volatile
PTB Ratio1.381.455.2033
Slightly volatile
Book Value Per Share19.6620.7491
Slightly volatile
Average Payables1 M947.2 K943.1 K
Slightly volatile
Stock Based Compensation To Revenue0.420.4451.2949
Slightly volatile
Capex To Depreciation0.810.854.1101
Slightly volatile
PB Ratio1.381.455.2033
Slightly volatile
EV To Sales9.099.572.1 K
Slightly volatile
Payables Turnover0.00870.00920.0112
Pretty Stable
Sales General And Administrative To Revenue0.01610.016944.2394
Slightly volatile
Research And Ddevelopement To Revenue3.063.22209
Slightly volatile
Capex To Revenue0.120.133.2282
Slightly volatile
Cash Per Share21.8723.02732
Slightly volatile
Days Payables Outstanding27.8 K41.1 K45.2 K
Slightly volatile
Income Quality0.831.00.818
Pretty Stable
Current Ratio8.676.0810.2299
Very volatile
Tangible Book Value Per Share19.6620.7491
Slightly volatile
Shareholders Equity Per Share19.6620.7491
Slightly volatile
Debt To Equity0.490.520.5881
Very volatile
Capex Per Share0.01390.01465.5473
Pretty Stable
Graham Net Net18.4719.44449
Slightly volatile
Revenue Per Share319303176
Slightly volatile
Interest Debt Per Share308444414
Slightly volatile
Debt To Assets0.340.290.2827
Very volatile
Price Book Value Ratio1.381.455.2033
Slightly volatile
Days Of Payables Outstanding27.8 K41.1 K45.2 K
Slightly volatile
Ebt Per Ebit0.980.871.1303
Very volatile
Company Equity Multiplier1.821.351.624
Pretty Stable
Long Term Debt To Capitalization0.360.31060.3186
Very volatile
Total Debt To Capitalization0.420.360.3347
Very volatile
Debt Equity Ratio0.490.520.5881
Very volatile
Quick Ratio8.676.0810.2299
Very volatile
Net Income Per E B T1.121.151.0345
Pretty Stable
Cash Ratio2.092.25.2738
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.151.0296
Slightly volatile
Price To Book Ratio1.381.455.2033
Slightly volatile
Fixed Asset Turnover4.294.092.4085
Slightly volatile
Debt Ratio0.340.290.2827
Very volatile
Price Sales Ratio9.9810.52.1 K
Slightly volatile
Asset Turnover0.170.160.0919
Slightly volatile
Price Fair Value1.381.455.2033
Slightly volatile

Forte Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap72.3 M76.2 M138.4 M
Slightly volatile
Enterprise Value48 M50.6 M130.5 M
Slightly volatile

Forte Fundamental Market Drivers

Forte Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Forte Biosciences Financial Statements

Forte Biosciences investors use historical fundamental indicators, such as Forte Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Forte Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-4.3 M-4.1 M
Cost Of Revenue44.9 K32.8 K
Stock Based Compensation To Revenue 0.44  0.42 
Sales General And Administrative To Revenue 0.02  0.02 
Research And Ddevelopement To Revenue 3.22  3.06 
Capex To Revenue 0.13  0.12 
Revenue Per Share 303.45  318.63 
Ebit Per Revenue(2.29)(2.40)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY